Target intelligence / Profile preview

Antigen-presenting cell plasma membrane

Molecular classification
Other (membrane structure), Contains: membrane proteins, including major histocompatibility complex (MHC) molecules, CD molecules (e.g., CD80, CD86, CD83), integrins, Fc receptors
01

Overview

The antigen-presenting cell plasma membrane refers to the lipid bilayer structure enveloping professional APCs, such as dendritic cells, macrophages, and B cells, which is densely populated with proteins essential for antigen uptake, processing, and interactive presentation to T cells. Central to adaptive immunity, the membrane hosts MHC complexes, co-stimulatory molecules, integrins, and signaling receptors; these organize at immune synapses to mediate precise cell communication and immune activation. Artificial APCs and membrane-based delivery systems exploit these features for therapeutic purposes, particularly in cancer and immunotherapy. This entry represents a structural component facilitating biological function rather than a distinct molecular target. For drug development, individual membrane proteins (such as MHC II, CD80, or CD86) are the usual therapeutic targets rather than the holistic "antigen-presenting cell membrane."

Other names
APC membraneplasma membrane of antigen-presenting cellcell membrane of APC
02

Mechanism of action

Drug delivery using APC-derived membranes: Antigen presentation and immune activation Therapeutic modulation of membrane proteins (e.g., blocking or stimulating co-stimulatory molecules, checkpoint inhibition) Vaccine strategies exploiting membrane antigen display for T cell priming

03

Biological functions

Antigen presentation (enables the display of processed antigens via MHC proteins to T cells)Immune synapse formation (surface for cell-cell interaction between APCs and T cells)Signal transduction (platform for clustering of immune receptors and co-stimulatory signals)Immune response activation (initiates and modulates adaptive immunity)
04

Disease associations

Cancer (immune evasion, immunotherapy target—see artificial APCs usage)Infection (presentation of pathogen antigens)Autoimmune disease (aberrant presentation of self-antigens)Inflammation (regulation via APC-T cell interactions)
05

Safety considerations

Non-specific immune activation leading to cytokine release or autoimmunityRisk of immune suppression if membrane proteins are incompletely or aberrantly expressedPotential off-target effects in engineered cell or membrane-based therapies
06

Interacting drugs

Artificial antigen-presenting cell-based therapies (engineered aAPCs)

2 more in the full profile.

07

Biomarkers

Expression of key membrane proteins (MHC class I/II, CD80, CD86, CD83)Specific antigen-MHC complexes for immune monitoringActivation markers on APC surface (e.g., upregulation of co-stimulatory molecules, cytokine-bound membrane proteins)

Beyond the preview

Go deeper on Antigen-presenting cell plasma membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Antigen-presenting cell plasma membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call